S&S Healthcare Holding (ROCO:4198) Cyclically Adjusted Revenue per Share: NT$27.63 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4198 S&S Healthcare Holding Ltd ROCO:4198
53 GF Score
Price NT$41.75
GF Value NT$21.98
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is S&S Healthcare Holding Cyclically Adjusted Revenue per Share?

S&S Healthcare Holding ROCO:4198 +0.60% 53 Cyclically Adjusted Revenue per Share is NT$27.63 as of Mar. 2026. GuruFocus rates ROCO:4198 with a GF Score™ of 53/100 and a GF Value™ of NT$21.98 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

S&S Healthcare Holding's adjusted revenue per share for the three months ended in Mar. 2026 was NT$1.648. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$27.63 for the trailing ten years ended in Mar. 2026.

During the past 12 months, S&S Healthcare Holding's average Cyclically Adjusted Revenue Growth Rate was -23.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -16.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of S&S Healthcare Holding was -16.60% per year. The lowest was -16.60% per year. And the median was -16.60% per year.

As of today (2026-08-15), S&S Healthcare Holding's current stock price is NT$41.75. S&S Healthcare Holding's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was NT$27.63. S&S Healthcare Holding's Cyclically Adjusted PS Ratio of today is 1.51.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of S&S Healthcare Holding was 1.64. The lowest was 0.41. And the median was 0.86.


S&S Healthcare Holding  (ROCO:4198) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

S&S Healthcare Holding's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=41.75/27.63
=1.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of S&S Healthcare Holding was 1.64. The lowest was 0.41. And the median was 0.86.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


S&S Healthcare Holding Cyclically Adjusted Revenue per Share Related Terms


S&S Healthcare Holding Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for S&S Healthcare Holding's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

S&S Healthcare Holding Cyclically Adjusted Revenue per Share Chart

S&S Healthcare Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 49.64 45.17 37.04 28.77

S&S Healthcare Holding Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.11 34.57 31.17 28.77 27.63

ROCO:4198 vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, S&S Healthcare Holding's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


S&S Healthcare Holding Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, S&S Healthcare Holding's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where S&S Healthcare Holding's Cyclically Adjusted PS Ratio falls into.


ROCO:4198
53GF Score
S&S Healthcare Holding Ltd ROCO:4198
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

S&S Healthcare Holding Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, S&S Healthcare Holding's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.648/330.2130*330.2130
=1.648

Current CPI (Mar. 2026) = 330.2130.

S&S Healthcare Holding Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 16.056 241.018 21.998
201609 10.737 241.428 14.686
201612 13.660 241.432 18.683
201703 15.281 243.801 20.697
201706 14.445 244.955 19.473
201709 10.755 246.819 14.389
201712 14.662 246.524 19.639
201803 11.127 249.554 14.723
201806 7.205 251.989 9.442
201809 10.430 252.439 13.643
201812 9.273 251.233 12.188
201903 6.443 254.202 8.370
201906 5.007 256.143 6.455
201909 6.710 256.759 8.630
201912 3.220 256.974 4.138
202003 2.125 258.115 2.719
202006 2.043 257.797 2.617
202009 2.175 260.280 2.759
202012 1.911 260.474 2.423
202103 2.347 264.877 2.926
202106 2.029 271.696 2.466
202109 1.705 274.310 2.052
202112 1.952 278.802 2.312
202203 3.482 287.504 3.999
202206 4.341 296.311 4.838
202209 4.325 296.808 4.812
202212 2.249 296.797 2.502
202303 2.651 301.836 2.900
202306 2.092 305.109 2.264
202309 3.395 307.789 3.642
202312 2.868 306.746 3.087
202403 2.867 312.332 3.031
202406 2.260 314.175 2.375
202409 2.473 315.301 2.590
202412 2.370 315.605 2.480
202503 2.769 319.799 2.859
202506 1.593 322.561 1.631
202509 1.831 324.800 1.862
202512 2.311 324.054 2.355
202603 1.648 330.213 1.648

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$27.63 mean?
S&S Healthcare Holding (ROCO:4198) has a Cyclically Adjusted Revenue per Share of NT$27.63 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on S&S Healthcare Holding and its competitors.
Is S&S Healthcare Holding's Cyclically Adjusted Revenue per Share too high?
S&S Healthcare Holding's current Cyclically Adjusted Revenue per Share is NT$27.63. Overall, S&S Healthcare Holding has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does S&S Healthcare Holding's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
S&S Healthcare Holding's Cyclically Adjusted Revenue per Share of NT$27.63 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on S&S Healthcare Holding and its competitors. S&S Healthcare Holding's current Cyclically Adjusted Revenue per Share is NT$27.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S&S Healthcare Holding stock overvalued right now?
Based on GuruFocus' analysis, S&S Healthcare Holding (ROCO:4198) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$21.98, compared to a current price of NT$41.75 — trading 89.9% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$27.63. S&S Healthcare Holding's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For S&S Healthcare Holding (ROCO:4198), the current Cyclically Adjusted Revenue per Share is NT$27.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is S&S Healthcare Holding (ROCO:4198) Overvalued in 2026?

Based on GuruFocus' analysis, S&S Healthcare Holding stock appears to be overvalued. The current stock price of NT$41.75 is trading 89.9% above its estimated GF Value™ of NT$21.98. GuruFocus considers S&S Healthcare Holding to be Significantly Overvalued.

Key valuation signals for ROCO:4198:

  • Cyclically Adjusted Revenue per Share: NT$27.63
  • GF Value™: NT$21.98 vs. price of NT$41.75 (89.9% above fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4198 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


S&S Healthcare Holding Business Description

Address 7th Floor, Number 89, Xinhu 1st Road, Taipei, TWN, 114
S&S Healthcare Holding Ltd, formerly Swissray Global Healthcare Holding Ltd is involved in providing DR systems designed for any application in general radiography. The product divisions of the company cover Swissray DDR systems, Novadaq, and EZ2GO. The main business projects of the company and its subsidiaries are the research and development, manufacturing, sales, and maintenance services of high-end medical equipment and the manufacturing and sales of basic medical equipment.
53GF Score

Get the complete analysis for ROCO:4198

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$41.75
Price
NT$21.98
GF Value